21% CAGR Propels NGS-Based RNA-Sequencing Market to $12.4 Billion by 2032 NGS-Based RNA-Sequencing Market Overview
The NGS-based RNA-sequencing market is flourishing, fueled by factors like NGS's superiority over traditional methods in terms of accuracy and coverage. Decreasing NGS costs and rising government research funding further accelerate this growth. A key trend is the increasing focus on personalized medicine and cancer research, where NGS-based RNA...
0 Shares
447 Views
0 Reviews